A controlled comparative clinical study to evaluate Gandharyadi ghrita nasya and Go ghrita nasya in the management of Ardhavabhedaka w.s.r to Migraine.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Response in headache
研究概览
简要总结
Migraine is a complex neurological disorder that manifests with recurrent headache, nausea, vomiting, photophobia or phonophobia. Theprevalence of migraine is 15% to 20% in women and 4% to 7% in men. In children the prevalence may be as high as 17% and isequal in boys and girls. The highest prevalence occur between the ages of 25yrs and 55 yrs. Based on sign and symptoms of Ardhavabhedaka. It can be compared with migraine. Objective of this study is to compare theefficacy of Gandharyadi ghrita nasya and Go ghrita nasya along with internalmedication as Narikela khanda in the management of Ardhavabhedaka. Study will conduct in AIIA hospital with taken 15patients in each groups by block randomization. Diagnosis of patient will bedone according Intrernational headache society for migraine. Primary assessmentparameter will pain and secondary will quality of life. Total duration of thisstudy will be 53days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having symptoms of Ardhavabhedaka , 1) Ardha parshwa Shirashoola– unilateral headache 2) Bheda , Toda, Shoola- pulsating , throbbing type of pain 3) Pakshat, Dashahat ,Akasmat- paroxysmal episodes.
- •Prakasha Asahishnata- photophobia, Nausea (Hrillas), vomiting (Chardi).
- •phonophobia.
排除标准
- •Known cases of Secondary headache caused by sinusitis , meningitis , brain tumour, increased intra ocular pressure , malignant HTN.
结局指标
主要结局
Response in headache
时间窗: Assesment will be done on baseline, 23day, 38day and 53day.
次要结局
- Overall improvement in quality of life.(assesment will be taken on baseline, on 23,38day and 53 day.)